Condividi
))
Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.
…
continue reading
BellaSeno trials next generation breast implant technology
Manage episode 361033714 series 3009792
Contenuto fornito da MTPConnect. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da MTPConnect o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
BellaSeno is a clinical-stage medical device company born in Queensland in 2015 and now expanded to Liepzig in Germany. They are developing a next generation fully resorbable breast implant for soft tissue reconstruction, which recently started clinical trials in Australia.
We connect with BellaSeno’s Co-Founder & Chief Executive Officer Dr Mohit Chhaya and Chief Medical Officer Dr Tobias Grossner in Germany, to discuss their ground-breaking 3D printing technology that aims to restore breast tissue. In a global collaboration, their team has been working with Queensland’s Herston Biofabrication Institute.
And Brisbane breast surgeon and Director of the Comprehensive Breast Cancer Institute, Professor Owen Ung, shares a clinicians view on the importance of this innovation for patients. Professor Ung is a principal investigator for a trial which began recently in Queensland.
MTPConnect hosts are Caroline Duell, Director Media and Communications and Andrew Bowskill, Director of Stakeholder Engagement for Queensland.
166 episodi
